Dyslipidemia and lipid management in HIV-infected patients
about
Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?Managing dyslipidemia in HIV/AIDS patients: challenges and solutionsHIV-1 Vpr enhances PPARβ/δ-mediated transcription, increases PDK4 expression, and reduces PDC activityStatin drug interactions and related adverse reactions.Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with PreserveHMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons.Changes in coronary heart disease risk profiles of HIV patients in Zimbabwe over 9 months: a follow-up study.The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges.Endocrine and metabolic abnormalities among HIV-infected patients: a current review.Statin therapy across the lifespan: evidence in major age groups.Astrocyte Elevated Gene-1 (AEG-1) and the A(E)Ging HIV/AIDS-HAND.Differences by HIV serostatus in coronary artery disease severity and likelihood of percutaneous coronary intervention following stress testing.How best to approach endocrine evaluation in patients with HIV in the era of combined antiretroviral therapy?HIV provider-patient communication regarding cardiovascular risk: results from the AIDS Treatment for Life International Survey.Cardiovascular disease in patients with HIV
P2860
Q27010594-42CDB77C-05CF-4C57-A219-688FF4B8BF4CQ28084941-3BCD31E2-9FCC-43B8-98DF-2C641067B79EQ28294338-35A84E85-221E-44C8-B499-7BC0F66DA95DQ34292468-14B25BD6-E9A1-499B-88AE-6C7C47428CEAQ37141511-353A0E6A-06F6-4D5D-8379-2A66EF199303Q37355991-CEF7E7A1-1A37-4B55-91F5-B6C2C2281152Q37381433-6E463F85-47ED-4CA0-89AF-366D26FC5D33Q38024436-EC17F9A5-E8C6-49A4-A46A-D1CE1FEA3EE9Q38130907-5A04B23A-077F-41A6-9B2D-BC887794EC19Q38660929-B9616FA6-1DDC-403A-96A6-FF5EA379EAEBQ38811225-82AAB982-3E4B-4903-A8B2-BA92F8AABC23Q39293076-68A9E79A-0166-4148-9CAE-6E5C7ED94813Q42289030-1A76EA89-A8FD-4C3F-902F-C5C06CECEEE5Q53091708-3CD7D4D1-C9C8-463E-B324-F208B8D0DDE1Q57681411-016C877C-8881-46E1-BFFE-4A8051C3F6D4
P2860
Dyslipidemia and lipid management in HIV-infected patients
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Dyslipidemia and lipid management in HIV-infected patients
@ast
Dyslipidemia and lipid management in HIV-infected patients
@en
type
label
Dyslipidemia and lipid management in HIV-infected patients
@ast
Dyslipidemia and lipid management in HIV-infected patients
@en
prefLabel
Dyslipidemia and lipid management in HIV-infected patients
@ast
Dyslipidemia and lipid management in HIV-infected patients
@en
P2860
P921
P1476
Dyslipidemia and lipid management in HIV-infected patients
@en
P2093
P2860
P304
P356
10.1097/MED.0B013E328344556E
P5008
P577
2011-04-01T00:00:00Z